Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Walker

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Annals of Internal Medicine|March 1, 1988
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudineR E Walker, R I Parker, J A Kovacs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twinsN Rebai, G Pantaleo, J F Demarest, et al.
Annals of Internal Medicine|July 1, 1989
Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trialH C Lane, J Falloon, R E Walker, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661R T Davey, R L Dewar, G F Reed, et al.
The New England Journal of Medicine|March 2, 1995
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary studyJ A Kovacs, M Baseler, R J Dewar, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruriaM A Polis, K M Spooner, B F Baird, et al.
AIDS (London, England)|September 14, 2000
Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppressionJ M Orenstein, N Bhat, C Yoder, et al.
Pharmacotherapy|December 28, 1999
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction studyJ Falloon, S Sargent, S C Piscitelli, et al.
The New England Journal of Medicine|October 31, 1996
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virusJ A Kovacs, S Vogel, J M Albert, et al.
The Journal of Infectious Diseases|April 1, 1997
Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected personsR T Davey, D G Chaitt, S C Piscitelli, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Annals of Internal Medicine|March 1, 1988
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudineR E Walker, R I Parker, J A Kovacs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twinsN Rebai, G Pantaleo, J F Demarest, et al.
Annals of Internal Medicine|July 1, 1989
Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trialH C Lane, J Falloon, R E Walker, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661R T Davey, R L Dewar, G F Reed, et al.
The New England Journal of Medicine|March 2, 1995
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary studyJ A Kovacs, M Baseler, R J Dewar, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruriaM A Polis, K M Spooner, B F Baird, et al.
AIDS (London, England)|September 14, 2000
Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppressionJ M Orenstein, N Bhat, C Yoder, et al.
Pharmacotherapy|December 28, 1999
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction studyJ Falloon, S Sargent, S C Piscitelli, et al.
The New England Journal of Medicine|October 31, 1996
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virusJ A Kovacs, S Vogel, J M Albert, et al.
The Journal of Infectious Diseases|April 1, 1997
Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected personsR T Davey, D G Chaitt, S C Piscitelli, et al.
Pageof 9